Literature DB >> 24785545

Thermodynamic and structural analysis of HIV protease resistance to darunavir - analysis of heavily mutated patient-derived HIV-1 proteases.

Milan Kožíšek1, Martin Lepšík, Klára Grantz Šašková, Jiří Brynda, Jan Konvalinka, Pavlína Rezáčová.   

Abstract

We report enzymologic, thermodynamic and structural analyses of a series of six clinically derived mutant HIV proteases (PR) resistant to darunavir. As many as 20 mutations in the resistant PRs decreased the binding affinity of darunavir by up to 13 000-fold, mostly because of a less favorable enthalpy of binding that was only partially compensated by the entropic contribution. X-ray structure analysis suggested that the drop in enthalpy of darunavir binding to resistant PR species was mostly the result of a decrease in the number of hydrogen bonds and a loosening of the fit between the inhibitor and the mutated enzymes. The favorable entropic contribution to darunavir binding to mutated PR variants correlated with a larger burial of the nonpolar solvent-accessible surface area upon inhibitor binding. We show that even very dramatic changes in the PR sequence leading to the loss of hydrogen bonds with the inhibitor could be partially compensated by the entropy contribution as a result of the burial of the larger nonpolar surface area of the mutated HIV PRs. DATABASE: Atomic coordinates and structure factors for the crystal structures PRwt-DRV and PRDRV2-DRV complex have been deposited in the Protein Data Bank under accession codes 4LL3 and 3TTP, respectively. STRUCTURED DIGITAL ABSTRACT: • PR and PR bind by x-ray crystallography (View interaction).
© 2014 FEBS.

Entities:  

Keywords:  HIV protease inhibitors; X‐ray crystallography; enthropic contribution; isothermal titration calorimetry; resistance mutation

Mesh:

Substances:

Year:  2014        PMID: 24785545     DOI: 10.1111/febs.12743

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  16 in total

1.  Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.

Authors:  Konda Reddy Karnati; Yixuan Wang
Journal:  J Mol Graph Model       Date:  2019-07-18       Impact factor: 2.518

Review 2.  Decoding HIV resistance: from genotype to therapy.

Authors:  Irene T Weber; Robert W Harrison
Journal:  Future Med Chem       Date:  2017-08-09       Impact factor: 3.808

Review 3.  Highly resistant HIV-1 proteases and strategies for their inhibition.

Authors:  Irene T Weber; Daniel W Kneller; Andres Wong-Sam
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

4.  Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.

Authors:  Debra A Ragland; Troy W Whitfield; Sook-Kyung Lee; Ronald Swanstrom; Konstantin B Zeldovich; Nese Kurt-Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2017-10-09       Impact factor: 6.006

5.  Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.

Authors:  Gordon J Lockbaum; Florian Leidner; Linah N Rusere; Mina Henes; Klajdi Kosovrasti; Gily S Nachum; Ellen A Nalivaika; Akbar Ali; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  ACS Infect Dis       Date:  2018-12-31       Impact factor: 5.084

6.  Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution.

Authors:  Zhanglong Liu; Xi Huang; Lingna Hu; Linh Pham; Katye M Poole; Yan Tang; Brian P Mahon; Wenxing Tang; Kunhua Li; Nathan E Goldfarb; Ben M Dunn; Robert McKenna; Gail E Fanucci
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

7.  Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance.

Authors:  Chinh Tran-To Su; Wei-Li Ling; Wai-Heng Lua; Yu-Xuan Haw; Samuel Ken-En Gan
Journal:  BMC Bioinformatics       Date:  2016-12-22       Impact factor: 3.169

8.  Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases.

Authors:  János András Mótyán; Márió Miczi; József Tőzsér
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 5.923

Review 9.  HIV Protease: Historical Perspective and Current Research.

Authors:  Irene T Weber; Yuan-Fang Wang; Robert W Harrison
Journal:  Viruses       Date:  2021-05-06       Impact factor: 5.048

10.  Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors.

Authors:  Gabriele La Monica; Antonino Lauria; Alessia Bono; Annamaria Martorana
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.